CDH1 and nonpapillary renal cell carcinoma: In ccRCC, miR-138 has a tumor suppressor role via the targeting of SOX4. The effects include the inhibited proliferation, migration, and invasion of tumor cells, increased expression of E-cadherin, and decreased expression of vimentin (Liu F. et al., 2017).